YOOZ Launches Comprehensive Laboratory to Meet New E-Cigarette Regulations

Aug.10.2022
YOOZ Launches Comprehensive Laboratory to Meet New E-Cigarette Regulations
YOOZ builds a comprehensive lab to promote research and innovation for electronic cigarettes, prioritizing quality and safety.

Starting from May 1, 2022, the mandatory national standard for electronic cigarettes was approved by the State Administration for Market Regulation and the National Standardization Management Committee. The "Regulations on the Management of Electronic Cigarettes" issued by the State Tobacco Monopoly Administration will also come into effect. The orderly implementation of the national standard and regulations not only marks the formal entry of the electronic cigarette industry into a phase with legal compliance, but also serves as a driving force for guiding electronic cigarette companies to gradually develop in the direction of scientific research and innovation. In order to better implement regulatory requirements and promote comprehensive innovation in the industry through scientific and technological innovation, YOOZ, a leading electronic cigarette company, has recently publicly launched a comprehensive laboratory built around CNAS standards.


In response, YOOZ, a department related to the company, stated that the implementation of both the national standard for electronic cigarettes and the new regulations is a boost for the long-term development of the industry. YOOZ has consistently relied on scientific research to support a more sustainable industry development strategy. This is both a responsibility and a necessary attitude for electronic cigarette companies to maintain a stable development trajectory.


With meticulous analysis, we always adhere to the principle of "customer first.


As we all know, consumers' greatest concerns always revolve around product quality and safety. Electronic cigarettes, which are often thought to have a low technological threshold, are at risk of having their quality and safety overlooked. However, the lower the technological threshold of a product, the greater the need for safety production and compliance. Prior to regulations being enforced, the electronic cigarette market was filled with various generic and fake products. Guarding consumer safety has become one of the crucial issues in the development of the industry. As a leading enterprise in the industry, YOOZ has always upheld the principle of "putting users first" and continuously strives to protect consumer rights.


Although e-cigarettes are often mocked as low-tech products, every production process and component must go through a rigorous and safe production process to prevent products with quality defects from entering the market. YOOZ's laboratory took half a year to prepare and put into use, and was built in accordance with CNAS standards. The testing center mainly consists of a physical laboratory, a chemical laboratory, an electrical laboratory, and an environmental laboratory, with more than 70 instruments and the ability to conduct over 100 standardized tests. YOOZ has a standardized testing method and strict quality management system in place for quality control and testing, thoroughly evaluating product performance, reliability, and safety throughout the product development process.


YOOZ Citrus Detection Center has developed simulated artificial smoking detection devices that mimic users' daily habits to provide more accurate experiences. Additionally, these devices help the company develop products that meet the needs of different users and provide more options. In addition, the batteries used in YOOZ products undergo over 400 cycles of charge and discharge in a longevity laboratory, as well as safety performance testing under various extreme conditions. This ensures that the product has good performance when frequently used by users.


It is noteworthy that the YOOZ Lemon Lab has taken the initiative to add a waterproof test in accordance with the National Standard for Electronic Cigarettes and the Measures for the Administration of Electronic Cigarettes. This demonstrates YOOZ Lemon's determination and implementation speed in compliance development, as well as their effort to improve and meet national standard requirements.


Moving towards research-oriented businesses is the development goal and mission of electronic cigarette companies.


YOOZ Laboratory not only bears the responsibility of safety and innovation, but also serves as a central hub that connects and streamlines the upstream and downstream industries. For businesses, the laboratory takes control of both research and production standards, leading to a more selective and high-quality choice of suppliers through strict requirements. This stimulates the development of the supply chain by reversing the stimulating effect of R&D capabilities, resulting in the production of safer, more environmentally friendly, and more cost-effective products that fully satisfy consumers' needs.


In the future, YOOZ will continue to prioritize consumer satisfaction and aim for long-term growth. They will spare no effort in ensuring compliance, safety, scientific research, innovation, and environmental friendliness, serving as a model for industry leaders. They will actively recruit talent and use their technological capabilities to push forward the development of the electronic cigarette industry, bringing more value to the industry's progress.


This article contains excerpts or reprints of third-party information, and the copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any unit or individual that needs to reprint, please contact the author and do not repost directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.
Regulations
Nov.11
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden's Public Health Agency has found ingredient labels on ZYN nicotine pouches sold by Philip Morris International subsidiary Swedish Match to be noncompliant, according to Dagens industri. The products' packaging listed 10 to 13 ingredients, compared with 11 to 42 in regulatory submissions, with multiple flavoring ingredients grouped under the generic term "aromer." The agency ordered corrective action, warning of a conditional penalty of SEK 2 million per month for noncompliance. The order applies only to products manufactured after the decision becomes legally effective and does not require recalls. Swedish Match disputes the agency's interpretation and plans to appeal.
PMI
Oct.22